Rating History for Pluristem Therapeutics (PSTI) by Dawson James

More Stocks Rated by Dawson James | Latest Ratings for PSTI
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/13/2022 Jason Kolbert Downgrade Neutral
(Buy)		 N/A
(N/A)		 1.19
(1.00)		 -15.97% Details